David W. Denning

David W. Denning is a British retired professor of infectious diseases and global health and medical mycology at the University of Manchester. He was the founding president, executive director and chief executive of Global Action For Fungal Infections (GAFFI) (2013-2023), which focusses on the global impact of fungal disease.

He became the director of the UK's National Aspergillosis Centre in Manchester, which treats people with chronic pulmonary aspergillosis (CPA), and led the group that produced the first guidelines for CPA in 2016. He retired from clinical practice in 2020.

Career David Denning studied medicine at Guy’s Hospital, London, and graduated in 1980. In 2009, he became the director of the UK's National Aspergillosis Centre in Manchester, which treats people with CPA.

In 2010, Denning was elected a Fellow of the Academy of Medical Sciences.

He is the founding president, executive director and chief executive of the GAFFI, which focusses on the global impact of fungal disease. Denning led the group that produced the first guidelines for CPA in 2016. He chairs the editorial board of a website which focusses on aspergillus and he leads an organisation which provides education on fungal diseases. In 2020, he retired from clinical practice.

Selected publications